Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
2.
Clin Ophthalmol ; 8: 1383-8, 2014.
Article in English | MEDLINE | ID: mdl-25092962

ABSTRACT

PURPOSE: To investigate the immediate effect of intravitreal injection of bevacizumab on intraocular pressure (IOP). METHODS: This was a prospective and nonrandomized study. A total of 291 eyes with macular edema or active choroidal neovascularization were submitted to a single 1.25 mg (0.05 mL) bevacizumab intravitreal injection. Intraocular pressure was measured with an Icare(®) tonometer immediately before and after injection in a seated position. The presence of subconjunctival reflux was recorded. The fellow eye served as the control. RESULTS: Mean preoperative IOP was 18.0±5.9 mmHg in the treated eye versus 16.9±6.0 mmHg in the fellow eye. Mean postoperative IOP was 42.1±14.5 mmHg in the treated eye versus 17.5±6.0 mmHg in the fellow eye. The IOP variation was statistically significant in both cases and controls (P<0.001 and P=0.003, respectively), and this increase was higher in cases than in controls (P<0.001). Postoperative IOPs higher than 50 mmHg were achieved in 32.0% of the eyes. Subconjunctival reflux was present in 21.3% and determined a lower IOP rise (P<0.001). Tested variables (glaucoma, phakic status, and sex) did not have a statistically significant effect on IOP rise or subconjunctival reflux. CONCLUSION: IOP increases with intravitreal bevacizumab injection, reaching 50 mmHg or more in about one third of patients. A higher IOP is expected if no subconjunctival reflux occurs. The baseline IOP does not influence the incidence of subconjunctival reflux. The clinical relevance of these facts has yet to be clarified.

3.
Clin Ophthalmol ; 8: 1475-8, 2014.
Article in English | MEDLINE | ID: mdl-25143707

ABSTRACT

The presence of pseudoexfoliation material on the surface of an intraocular lens (IOL) is a rare finding. We report a series of seven cases with different patterns of pseudoexfoliation material deposition on the posterior chamber IOLs, recognized 2-20 years after cataract surgery. Six patients had an IOL implanted in the capsular bag and one in the ciliary sulcus. Two patients had undergone posterior capsulotomy. Although the pathophysiological mechanisms and clinical significance of this finding remain unknown, the careful follow-up of pseudophakic patients with known or suspected pseudoexfoliation syndrome is essential to monitor the development or progression of glaucoma, since deposition of pseudoexfoliation material continues even after cataract surgery.

4.
J Ophthalmic Vis Res ; 7(4): 281-8, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23503604

ABSTRACT

PURPOSE: To report the outcomes of two different surgical techniques for the repair of late onset bleb leakage following trabeculectomy. METHODS: This retrospective study includes 21 eyes of 20 patients with prior trabeculectomy and late-onset bleb leaks; 14 eyes underwent excision of the filtering bleb together with conjunctival advancement while in the other 7 eyes the bleb was retained but de-epithelialized before conjunctival advancement. Success was defined as resolution of leakage with no need for additional glaucoma surgery together with intraocular pressure (IOP) of 5-21 mmHg. Complete and qualified success was considered when the above mentioned was achieved without or with glaucoma medications, respectively. RESULTS: Mean duration of follow-up was 20.3±14.4 months. No significant difference was observed between the two groups in terms of complete, qualified and overall success rates (P>0.05), however more antiglaucoma medications were necessary in the bleb excision group (P=0.02). CONCLUSIONS: Both surgical techniques of bleb repair were comparably effective, however the bleb de-epithelialization technique was associated with less need for glaucoma medications after the procedure.

5.
Ophthalmic Surg Lasers Imaging ; 41(3): 383-5, 2010.
Article in English | MEDLINE | ID: mdl-20507025

ABSTRACT

Blebs resulting from glaucoma filtration surgery tend to result in lower intraocular pressure and to be associated with fewer complications when they are diffuse and spread over the globe rather than localized to the area over the scleral flap. One way to achieve this type of bleb morphology is by applying the antimetabolite to a larger area than the one usually used in the past, in which the antimetabolite was placed only over the area of the scleral flap. In this article, the authors present a safe and inexpensive technique, which consists of using sponges with long, colored tails. This allows applying antimetabolite as far under the Tenon's capsule as desired without the risk of losing the sponges in the sub-Tenon's space.


Subject(s)
Antimetabolites/administration & dosage , Filtering Surgery/methods , Glaucoma/surgery , Administration, Topical , Glaucoma/drug therapy , Humans , Intraocular Pressure , Intraoperative Period , Postoperative Complications/prevention & control , Surgical Sponges , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...